A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY)

A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis